{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:29:43Z","timestamp":1795008583041,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["No.JCY2022053142211026"],"award-info":[{"award-number":["No.JCY2022053142211026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01350-y","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:36:03Z","timestamp":1769243763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hsa_circ_0003176: a key player in the m6A modification-mediated regulation of autophagy and glycolysis in cisplatin-resistant non-small cell lung cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Sujuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7877-4005","authenticated-orcid":false,"given":"Lei","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102315","volume":"97","author":"SK Jha","year":"2024","unstructured":"Jha SK, De Rubis G, Devkota SR, et al. Cellular senescence in lung cancer: molecular mechanisms and therapeutic interventions. Ageing Res Rev. 2024;97:102315. https:\/\/doi.org\/10.1016\/j.arr.2024.102315.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1350_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/10408363.2024.2302116","volume":"61","author":"A Ntzifa","year":"2024","unstructured":"Ntzifa A, Marras T, Georgoulias V, Lianidou E. Liquid biopsy for the management of NSCLC patients under osimertinib treatment. Crit Rev Clin Lab Sci. 2024;61(5):347\u201369. https:\/\/doi.org\/10.1080\/10408363.2024.2302116.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"1350_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12890-024-03178-4","volume":"24","author":"M Zahmatyar","year":"2024","unstructured":"Zahmatyar M, Kharaz L, Abiri Jahromi N, Jahanian A, Shokri P, Nejadghaderi SA. The safety and efficacy of binimetinib for lung cancer: a systematic review. BMC Pulm Med. 2024;24(1):379. https:\/\/doi.org\/10.1186\/s12890-024-03178-4.","journal-title":"BMC Pulm Med"},{"issue":"8","key":"1350_CR4","first-page":"4456","volume":"12","author":"R Wang","year":"2020","unstructured":"Wang R, Chen C, Kang W, Meng G. SNHG9 was upregulated in NSCLC and associated with DDP-resistance and poor prognosis of NSCLC patients. Am J Transl Res. 2020;12(8):4456\u201366.","journal-title":"Am J Transl Res"},{"key":"1350_CR5","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.2147\/cmar.S246299","volume":"12","author":"Y Zhan","year":"2020","unstructured":"Zhan Y, Abuduwaili K, Wang X, Shen Y, Nuerlan S, Liu C. Knockdown of long non-coding RNA HOTAIR suppresses cisplatin resistance, cell proliferation, migration and invasion of DDP-resistant NSCLC cells by targeting miR-149-5p\/doublecortin-like kinase 1 axis. Cancer Manag Res. 2020;12:7725\u201337. https:\/\/doi.org\/10.2147\/cmar.S246299.","journal-title":"Cancer Manag Res"},{"key":"1350_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121503","author":"F Xu","year":"2024","unstructured":"Xu F, Xiao Q, Du WW, Wang S, Yang BB. Circrna: functions, applications and prospects. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14121503.","journal-title":"Biomolecules"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","volume":"348","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang Y, Zhou S, Dain L, Mei L, Zhu G. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Control Release. 2022;348:84\u201394. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.043.","journal-title":"J Control Release"},{"issue":"1","key":"1350_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172. https:\/\/doi.org\/10.1186\/s12943-020-01286-3.","journal-title":"Mol Cancer"},{"key":"1350_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.004.","journal-title":"Cancer Lett"},{"issue":"1","key":"1350_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01840-7","volume":"22","author":"N Feng","year":"2021","unstructured":"Feng N, Guo Z, Wu X, et al. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p\/ROCK1 axis. Respir Res. 2021;22(1):248. https:\/\/doi.org\/10.1186\/s12931-021-01840-7.","journal-title":"Respir Res"},{"key":"1350_CR11","doi-asserted-by":"publisher","first-page":"8402116","DOI":"10.1155\/2022\/8402116","volume":"2022","author":"F Yang","year":"2022","unstructured":"Yang F, Pei Y, Xu W, Rong L. hsa_circ_0003176 suppresses the progression of non-small-cell lung cancer via regulating miR-182-5p\/RBM5 axis. Dis Markers. 2022;2022:8402116. https:\/\/doi.org\/10.1155\/2022\/8402116.","journal-title":"Dis Markers"},{"issue":"5","key":"1350_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.canep.2012.04.004","volume":"36","author":"P Li","year":"2012","unstructured":"Li P, Wang K, Zhang J, et al. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Cancer Epidemiol. 2012;36(5):481\u20139. https:\/\/doi.org\/10.1016\/j.canep.2012.04.004.","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"1350_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375. https:\/\/doi.org\/10.1038\/s41580-023-00585-z.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1350_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00726-023-03364-4","volume":"56","author":"LB Kwantwi","year":"2024","unstructured":"Kwantwi LB. The dual role of autophagy in the regulation of cancer treatment. Amino Acids. 2024;56(1):7. https:\/\/doi.org\/10.1007\/s00726-023-03364-4.","journal-title":"Amino Acids"},{"key":"1350_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032606","author":"C Chelakkot","year":"2023","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating glycolysis to improve cancer therapy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032606.","journal-title":"Int J Mol Sci"},{"key":"1350_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115787","author":"L Alberghina","year":"2023","unstructured":"Alberghina L. The warburg effect explained: integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242115787.","journal-title":"Int J Mol Sci"},{"key":"1350_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.861959","volume":"12","author":"W Guo","year":"2022","unstructured":"Guo W, Du K, Luo S, Hu D. Recent advances of autophagy in non-small cell lung cancer: from basic mechanisms to clinical application. Front Oncol. 2022;12:861959. https:\/\/doi.org\/10.3389\/fonc.2022.861959.","journal-title":"Front Oncol"},{"key":"1350_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1037341","volume":"13","author":"JQ Xu","year":"2022","unstructured":"Xu JQ, Fu YL, Zhang J, et al. Targeting glycolysis in non-small cell lung cancer: promises and challenges. Front Pharmacol. 2022;13:1037341. https:\/\/doi.org\/10.3389\/fphar.2022.1037341.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1350_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4149\/neo_2022_211013N1449","volume":"69","author":"XP Yang","year":"2022","unstructured":"Yang XP, Zheng YZ, Tan J, et al. Circ_0020123 regulates autophagy, glycolysis, and malignancy by upregulating IRF4 through eliminating miR-193a-3p-mediated suppression of IRF4 in non-small cell lung cancer. Neoplasma. 2022;69(2):392\u2013403. https:\/\/doi.org\/10.4149\/neo_2022_211013N1449.","journal-title":"Neoplasma"},{"issue":"3","key":"1350_CR20","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1080\/21655979.2022.2031385","volume":"13","author":"F Zhang","year":"2022","unstructured":"Zhang F, Zhang T, Zhao Z, Ji Y, Peng Y, Zhao L. Circular RNA Eps15-homology domain containing protein 2 motivates proliferation, glycolysis but refrains autophagy in non-small cell lung cancer via crosstalk with microRNA-3186-3p and forkhead box K1. Bioengineered. 2022;13(3):6464\u201375. https:\/\/doi.org\/10.1080\/21655979.2022.2031385.","journal-title":"Bioengineered"},{"issue":"1","key":"1350_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4.","journal-title":"Mol Cancer"},{"issue":"1","key":"1350_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"1350_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.tins.2020.09.005","volume":"43","author":"SU Madugalle","year":"2020","unstructured":"Madugalle SU, Meyer K, Wang DO, Bredy TW. RNA N(6)-methyladenosine and the regulation of RNA localization and function in the brain. Trends Neurosci. 2020;43(12):1011\u201323. https:\/\/doi.org\/10.1016\/j.tins.2020.09.005.","journal-title":"Trends Neurosci"},{"key":"1350_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251342685","volume":"32","author":"Y Zhi","year":"2025","unstructured":"Zhi Y, Liu S, Chang X, et al. M6A methylation regulators METTL3 and ALKBH5 are risk factors for EGFR-mutant NSCLC. Cancer Control. 2025;32:10732748251342685. https:\/\/doi.org\/10.1177\/10732748251342685.","journal-title":"Cancer Control"},{"issue":"2","key":"1350_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s13577-022-00835-w","volume":"36","author":"J Tang","year":"2023","unstructured":"Tang J, Huang M, Peng H, et al. METTL3-mediated Hsa_circ_0000390 downregulation enhances the proliferation, migration, and invasion of colorectal cancer cells by increasing Notch1 expression. Hum Cell. 2023;36(2):703\u201311. https:\/\/doi.org\/10.1007\/s13577-022-00835-w.","journal-title":"Hum Cell"},{"issue":"1","key":"1350_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20(1):105. https:\/\/doi.org\/10.1186\/s12943-021-01398-4.","journal-title":"Mol Cancer"},{"issue":"17","key":"1350_CR27","doi-asserted-by":"publisher","first-page":"24510","DOI":"10.18632\/oncotarget.8229","volume":"7","author":"QY Chen","year":"2016","unstructured":"Chen QY, Jiao DM, Wang J, et al. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Oncotarget. 2016;7(17):24510\u201326. https:\/\/doi.org\/10.18632\/oncotarget.8229.","journal-title":"Oncotarget"},{"key":"1350_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168885","author":"J Kryczka","year":"2021","unstructured":"Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia\u0144ska-Lasota E. Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22168885.","journal-title":"Int J Mol Sci"},{"key":"1350_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153370","volume":"80","author":"JS Lou","year":"2021","unstructured":"Lou JS, Zhao LP, Huang ZH, et al. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2\/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomedicine. 2021;80:153370. https:\/\/doi.org\/10.1016\/j.phymed.2020.153370.","journal-title":"Phytomedicine"},{"issue":"1","key":"1350_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-025-05683-z","volume":"82","author":"PC Hu","year":"2025","unstructured":"Hu PC, Yao JT, Wang KJ, et al. Research progress on circular RNA in the regulation of drug resistance in genitourinary cancers. Cell Mol Life Sci. 2025;82(1):158. https:\/\/doi.org\/10.1007\/s00018-025-05683-z.","journal-title":"Cell Mol Life Sci"},{"key":"1350_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.omtn.2021.01.002","volume":"23","author":"W Cui","year":"2021","unstructured":"Cui W, Dang Q, Chen C, Yuan W, Sun Z. Roles of circRNAs on tumor autophagy. Mol Ther Nucleic Acids. 2021;23:918\u201329. https:\/\/doi.org\/10.1016\/j.omtn.2021.01.002.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1350_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082229","author":"X Luo","year":"2023","unstructured":"Luo X, Peng Y, Fan X, Xie X, Jin Z, Zhang X. The crosstalk and clinical implications of circRNAs and glucose metabolism in gastrointestinal cancers. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15082229.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1350_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04216-3","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang X, Cao J, et al. Circular RNA UBE2Q2 promotes malignant progression of gastric cancer by regulating signal transducer and activator of transcription 3-mediated autophagy and glycolysis. Cell Death Dis. 2021;12(10):910. https:\/\/doi.org\/10.1038\/s41419-021-04216-3.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1350_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ncrna.2023.08.003","volume":"8","author":"S Gupta","year":"2023","unstructured":"Gupta S, Silveira DA, Mombach JCM, Hashimoto RF. The lncRNA DLX6-AS1\/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: a boolean model of cell death. Noncoding RNA Res. 2023;8(4):605\u201314. https:\/\/doi.org\/10.1016\/j.ncrna.2023.08.003.","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"1350_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117. https:\/\/doi.org\/10.1186\/s13045-020-00951-w.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1350_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27(5):626\u201341. https:\/\/doi.org\/10.1038\/cr.2017.31.","journal-title":"Cell Res"},{"issue":"5","key":"1350_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.21037\/tlcr-24-85","volume":"13","author":"X Su","year":"2024","unstructured":"Su X, Feng Y, Qu Y, Mu D. Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications. Transl Lung Cancer Res. 2024;13(5):1121\u201336. https:\/\/doi.org\/10.21037\/tlcr-24-85.","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"1350_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-025-10421-7","volume":"56","author":"W Lin","year":"2025","unstructured":"Lin W, Huang L, Ou Z, et al. N6-methyladenosine-modified circ_0000517 promotes non-small cell lung cancer metastasis via miR-1233-3p\/CDH6 axis. J Mol Histol. 2025;56(3):139. https:\/\/doi.org\/10.1007\/s10735-025-10421-7.","journal-title":"J Mol Histol"},{"issue":"6","key":"1350_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","volume":"15","author":"PJ Batista","year":"2014","unstructured":"Batista PJ, Molinie B, Wang J, et al. m(6)A rna modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15(6):707\u201319. https:\/\/doi.org\/10.1016\/j.stem.2014.09.019.","journal-title":"Cell Stem Cell"},{"issue":"14","key":"1350_CR40","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.14.40","volume":"65","author":"X Jiang","year":"2024","unstructured":"Jiang X, Sun K, Fan Y, et al. Mettl3-mediated m6A modification is essential for visual function and retinal photoreceptor survival. Invest Ophthalmol Vis Sci. 2024;65(14):40. https:\/\/doi.org\/10.1167\/iovs.65.14.40.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1350_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000526035","volume":"162","author":"S Chen","year":"2022","unstructured":"Chen S, Dong J, Luo X, et al. Interaction between m6A and ncRNAs and its association with diseases. Cytogenet Genome Res. 2022;162(4):171\u201387. https:\/\/doi.org\/10.1159\/000526035.","journal-title":"Cytogenet Genome Res"},{"issue":"3","key":"1350_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cai2.28","volume":"1","author":"J Cui","year":"2022","unstructured":"Cui J, Chen M, Zhang L, Huang S, Xiao F, Zou L. Circular rnas: biomarkers of cancer. Cancer Innov. 2022;1(3):197\u2013206. https:\/\/doi.org\/10.1002\/cai2.28.","journal-title":"Cancer Innov"},{"issue":"11","key":"1350_CR43","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular rnas. Nat Rev Genet. 2019;20(11):675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"key":"1350_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna11040053","author":"R Garraffo","year":"2025","unstructured":"Garraffo R, Beltran Nebot M. Direct circRNA-mRNA binding controls mRNA fate: a new mechanism for circRNAs. Noncoding RNA. 2025. https:\/\/doi.org\/10.3390\/ncrna11040053.","journal-title":"Noncoding RNA"},{"issue":"8","key":"1350_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182891","volume":"12","author":"B Chen","year":"2017","unstructured":"Chen B, Yang L, Zhang R, et al. Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients. PLoS ONE. 2017;12(8):e0182891. https:\/\/doi.org\/10.1371\/journal.pone.0182891.","journal-title":"PLoS ONE"},{"issue":"9","key":"1350_CR46","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1080\/15548627.2020.1812218","volume":"17","author":"DS Oh","year":"2021","unstructured":"Oh DS, Park JH, Jung HE, Kim HJ, Lee HK. Autophagic protein ATG5 controls antiviral immunity via glycolytic reprogramming of dendritic cells against respiratory syncytial virus infection. Autophagy. 2021;17(9):2111\u201327. https:\/\/doi.org\/10.1080\/15548627.2020.1812218.","journal-title":"Autophagy"},{"issue":"21","key":"1350_CR47","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1158\/1078-0432.Ccr-15-0217","volume":"21","author":"C Cai","year":"2015","unstructured":"Cai C, Chen QB, Han ZD, et al. miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate cancer. Clin Cancer Res. 2015;21(21):4922\u201334. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-0217.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1350_CR48","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004.","journal-title":"Cell"},{"issue":"7396","key":"1350_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 2012;485(7396):109\u201313. https:\/\/doi.org\/10.1038\/nature11083.","journal-title":"Nature"},{"issue":"6","key":"1350_CR50","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molcel.2017.08.011","volume":"67","author":"M Nofal","year":"2017","unstructured":"Nofal M, Zhang K, Han S, Rabinowitz JD. mTOR inhibition restores amino acid balance in cells dependent on catabolism of extracellular protein. Mol Cell. 2017;67(6):936-946.e5. https:\/\/doi.org\/10.1016\/j.molcel.2017.08.011.","journal-title":"Mol Cell"},{"issue":"11","key":"1350_CR51","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s42255-023-00912-w","volume":"5","author":"X Dou","year":"2023","unstructured":"Dou X, Fu Q, Long Q, et al. PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. Nat Metab. 2023;5(11):1887\u2013910. https:\/\/doi.org\/10.1038\/s42255-023-00912-w.","journal-title":"Nat Metab"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01350-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:36:04Z","timestamp":1769243764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01350-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01350-y","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study involving human cell lines and animal experiments was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Hong Kong-Shenzhen Hospital. All animal experiments were reviewed and approved by the Animal Ethical Committee of the University of Hong Kong-Shenzhen Hospital. The study was carried out in compliance with the ARRIVE guidelines for reporting animal experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"38"}}